BAM
Bellevue Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Hold |
10,335
| – | – | 0.06% | 95 |
|
|
2025
Q1 | $76.8K | Hold |
10,335
| – | – | 0.04% | 119 |
|
|
2024
Q4 | $62K | Hold |
10,335
| – | – | 0.03% | 135 |
|
|
2024
Q3 | $52.9K | Hold |
10,335
| – | – | 0.03% | 158 |
|
|
2024
Q2 | $37.4K | Hold |
10,335
| – | – | 0.02% | 175 |
|
|
2024
Q1 | $33.2K | Sell |
10,335
-250
| -2% | -$802 | 0.02% | 186 |
|
|
2023
Q4 | $51.9K | Hold |
10,585
| – | – | 0.05% | 146 |
|
|
2023
Q3 | $57.7K | Hold |
10,585
| – | – | 0.04% | 121 |
|
|
2023
Q2 | $70.9K | Hold |
10,585
| – | – | 0.04% | 117 |
|
|
2023
Q1 | $93.5K | Hold |
10,585
| – | – | 0.06% | 93 |
|
|
2022
Q4 | $78.8K | Sell |
10,585
-162
| -2% | -$1.21K | 0.06% | 110 |
|
|
2022
Q3 | $77K | Hold |
10,747
| – | – | 0.06% | 114 |
|
|
2022
Q2 | $85K | Hold |
10,747
| – | – | 0.06% | 108 |
|
|
2022
Q1 | $152K | Hold |
10,747
| – | – | 0.09% | 85 |
|
|
2021
Q4 | $302K | Sell |
10,747
-150
| -1% | -$4.22K | 0.18% | 57 |
|
|
2021
Q3 | $371K | Buy |
10,897
+310
| +3% | +$10.6K | 0.23% | 49 |
|
|
2021
Q2 | $433K | Hold |
10,587
| – | – | 0.26% | 44 |
|
|
2021
Q1 | $430K | Buy |
10,587
+162
| +2% | +$6.58K | 0.27% | 48 |
|
|
2020
Q4 | $671K | Hold |
10,425
| – | – | 0.41% | 38 |
|
|
2020
Q3 | $507K | Hold |
10,425
| – | – | 0.35% | 42 |
|
|
2020
Q2 | $504K | Hold |
10,425
| – | – | 0.52% | 39 |
|
|
2020
Q1 | $335K | Buy |
10,425
+10,150
| +3,691% | +$326K | 0.35% | 54 |
|
|
2019
Q4 | $8K | Buy |
+275
| New | +$8K | 0.01% | 324 |
|